Hypothyroidism and the Heart
References
- Danzi S Klein I. Thyroid disease and the cardiovascular system. Endocrinol Metab Clin North Am. 2014 Jun; 43 2: 517– 28.
- Vargas-Uricoechea H , Bonelo-Perdomo A , Sierra-Torres CH. Effects of thyroid hormones on the heart. Clin Investig Arterioscler. 2014 Nov–Dec; 26 6: 296– 309.
- Klein I Danzi S. Thyroid disease and the heart. Circulation. 2007 Oct 9; 116 15: 1725– 35.
- Klein I Danzi S. Thyroid disease and the heart. Curr Probl Cardiol. 2016 Feb; 41 2: 65– 92.
- Gardner D Shoback D. Greenspan's basic and clinical endocrinology. 9th ed. New York: McGraw-Hill Education; 2011. 896 p.
- Nabbout LA Robbins RJ. The cardiovascular effects of hyperthyroidism. Methodist DeBakey Cardiovasc J. 2010 Apr–Jun; 6 2: 3– 8.
- Vallabhajosula S , Radhi S , Cevik C , Alalawi R , Raj R , Nugent K. Hyperthyroidism and pulmonary hypertension: an important association. Am J Med Sci. 2011 Dec; 342 6: 507– 12.
- Siu CW , Zhang XH , Yung C , Kung AW , Lau CP , Tse HF. Hemodynamic changes in hyperthyroidism-related pulmonary hypertension: a prospective echocardiographic study. J Clin Endocrinol Metab. 2007 May; 92 5: 1736– 42.
- Sugiura T , Yamanaka S , Takeuchi H , Morimoto N , Kamioka M , Matsumura Y. Autoimmunity and pulmonary hypertension in patients with Graves' disease. Heart Vessels. 2015 Sep; 30 5: 642– 6.
- Klein I Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med. 2001 Feb 15; 344 7: 501– 9.
- Biondi B. Mechanisms in endocrinology: Heart failure and thyroid dysfunction. Eur J Endocrinol. 2012 Nov; 167 5: 609– 18.
- Mitchell JE , Hellkamp AS , Mark DB , Thyroid function in heart failure and impact on mortality. JACC Heart Fail. 2013 Feb; 1 1: 48– 55.
- Tomisti L , Materazzi G , Bartalena L , Total thyroidectomy in patients with amiodarone-induced thyrotoxicosis and severe left ventricular systolic dysfunction. J Clin Endocrinol Metab. 2012 Oct; 97 10: 3515– 21.
- Al-Ghamdi AS Aljohani N. Graves' thyrotoxicosis-induced reversible cardiomyopathy: a case report. Clin Med Insights Case Rep. 2013 Mar 27; 6: 47– 50.
- Choudhury RP MacDermot J. Heart failure in thyrotoxicosis, an approach to management. Br J Clin Pharmacol. 1998 Nov; 46 5: 421– 4.
- Osman F , Franklyn JA , Holder RL , Sheppard MC , Gammage MD. Cardiovascular manifestations of hyperthyroidism before and after antithyroid therapy: a matched case-control study. J Am Coll Cardiol. 2007 Jan 2; 49 1: 71– 81.
- Bielecka-Dabrowa A , Mikhailidis DP , Rysz J , Banach M. The mechanisms of atrial fibrillation in hyperthyroidism. Thyroid Res. 2009 Apr 2; 2 1: 4.
- Tănase DM , Ionescu SD , Ouatu A , Ambăruş V , Arsenescu-Georgescu C. Risk assessment in the development of atrial fibrillation at patients with associate thyroid dysfunctions. Rev Med Chir Soc Med Nat Iasi. 2013 Jul–Sep; 117 3: 623– 9.
- Chaker L , Heeringa J , Dehghan A , Normal Thyroid Function and the Risk of Atrial Fibrillation: the Rotterdam Study. J Clin Endocrinol Metab. 2015 Oct; 100 10: 3718– 24.
- Staffurth JS , Gibberd MC , Fui SN. Arterial embolism in thyrotoxicosis with atrial fibrillation. Br Med J. 1977 Sep 10; 2 6088: 688– 90.
- Frost L , Vestergaard P , Mosekilde L. Hyperthyroidism and risk of atrial fibrillation or flutter: a population-based study. Arch Intern Med. 2004 Aug 9–23; 164 15: 1675– 8.
- Sawin CT , Geller A , Wolf PA , Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med. 1994 Nov 10; 331 19: 1249– 52.
- Bogazzi F , Bartalena L , Martino E. Approach to the patient with amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab. 2010 Jun; 95 6: 2529– 35.
- Kahaly GJ Dillmann WH. Thyroid hormone action in the heart. Endocr Rev. 2005 Aug; 26 5: 704– 28.
- Conen D , Melly L , Kaufmann C , Amiodarone-induced thyrotoxicosis: clinical course and predictors of outcome. J Am Coll Cardiol. 2007 Jun 19; 49 24: 2350– 5.
- Surks MI , Ortiz E , Daniels GH , Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA. 2004 Jan 14; 291 2: 228– 38.
- Biondi B , Palmieri EA , Lombardi G , Fazio S. Effects of subclinical thyroid dysfunction on the heart. Ann Intern Med. 2002 Dec 3; 137 11: 904– 14.
- Biondi B , Bartalena L , Cooper DS , Hegedus L , Laurberg P , Kahaly GJ. The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism. Eur Thyroid J. 2015 Sep; 4 3: 149– 63.
- Nanchen D , Gussekloo J , Westendorp RG , Subclinical thyroid dysfunction and the risk of heart failure in older persons at high cardiovascular risk. J Clin Endocrinol Metab. 2012 Mar; 97 3: 852– 61.
- Selmer C , Olesen JB , Hansen ML , The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large population cohort study. BMJ. 2012 Nov 27; 345: e7895.
- Selmer C , Olesen JB , Hansen ML , Subclinical and overt thyroid dysfunction and risk of all-cause mortality and cardiovascular events: a large population study. J Clin Endocrinol Metab. 2014 Jul; 99 7: 2372– 82.
DOI: https://doi.org/10.14797/mdcj-13-2-60 | Journal eISSN: 1947-6108
Language: English
Page range: 60 - 63
Published on: Apr 1, 2017
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services
© 2017 Patricia Mejia Osuna, Maja Udovcic, Morali D. Sharma, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.